AI Proteins
1 known investors
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
AI & Machine LearningBiotechDeep Tech
Investors · 1
In the news
- AI Proteins - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2025
- AI Proteins - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2025
- AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality - BioSpacebiospace.com · 2025
- AI Proteins Raises $41.5M Series A | citybizcitybiz.co · 2025
- Exclusive: AI Proteins raises $42M Series A, and will launch miniproteins into hub-and-spoke modelendpoints.news · 2025
- AI Proteins Raises $18.2M in Seed Fundingfinsmes.com · 2022